Metabolic and mitochondrial alterations in children with autism spectrum disorder: The role of FGF-21 and GDF-15
Clinica Chimica Acta · 2026
DOI: 10.1016/j.cca.2026.120979 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinica Chimica Acta, 2026. Verfasst von Ayla Yildiz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Başakşehir Çam and Sakura City Hospital, Istanbul, Türkiye. Electronic address: aylayildizm@gmail.com. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Autism Spectrum Disorder, Growth Differentiation Factor 15, Mitochondria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
INTRODUCTION: Autism Spectrum Disorder (ASD) is a neurodevelopmental condition marked by social communication deficits and repetitive behaviors. Evidence suggests that metabolic and mitochondrial stress contribute to ASD. Fibroblast growth factor 21 (FGF-21) and growth differentiation factor 15 (GDF-15) are circulating markers of mitochondrial dysfunction and cellular stress, but their role in pediatric ASD remains underexplored. METHODS: Case-control study involved 118 children: 88 with ASD (DSM-5 criteria) and 30 healthy controls matched by age and sex. ASD patients were divided by Autism Behavior Checklist (ABC) scores into Group I (ABC >60, n = 48) and Group II (ABC ≤60, n = 40). FGF-21 and GDF-15 were measured by ELISA. Biochemical parameters, hemogram, plasma amino acids (LC-MS/MS), and urinary organic acids (GC-MS) were analyzed. Statistical analyses included Kruskal-Wallis, Spearman correlation and ROC. RESULTS: FGF-21 was significantly elevated in ASD compared to controls (p 0.05). ASD showed increased lactate, lactate/pyruvate ratio, urea, AST, LDH, LDL, lymphocyte and platelet counts, and decreased pyruvate, serum and urinary creatinine (p < 0.05). Essential and branched-chain amino acids decreased, whereas glycine and histidine increased (p < 0.05). FGF-21 correlated weakly but significantly with mitochondrial dysfunction and amino acid metabolism markers. ROC showed good diagnostic accuracy for FGF-21 in ASD (AUC = 0.817), with 98.9% sensitivity and 73.3% specificity at 27.9 pg/mL cut-off. Urinary organic acids, methylmalonic acid, tiglylglycine, and 2-ketoisocaproic acid, were significantly elevated (p < 0.05). CONCLUSION: Elevated serum FGF-21 in children with ASD is linked to metabolic alterations, whereas GDF-15 remains unchanged. These results suggest FGF-21's association with metabolic dysregulation in ASD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biochemistry, Başakşehir Çam and Sakura City Hospital, Istanbul, Türkiye. Electronic address: aylayildizm@gmail.com.
- Department of Pediatric Nutrition and Metabolic Diseases, Cam and Sakura City Hospital, Istanbul, Türkiye.
- Department of Pediatric Nutrition and Metabolic Diseases, Cam and Sakura City Hospital, Istanbul, Türkiye. Electronic address: hasanonal@sbu.edu.tr.
Zitieren
APA
Yildiz, A., Topuz, H. S., & Onal, H. (2026). Metabolic and mitochondrial alterations in children with autism spectrum disorder: The role of FGF-21 and GDF-15. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2026.120979
Vancouver
Yildiz A, Topuz HS, Onal H. Metabolic and mitochondrial alterations in children with autism spectrum disorder: The role of FGF-21 and GDF-15. Clinica Chimica Acta. 2026. doi:10.1016/j.cca.2026.120979
BibTeX
@article{Yildiz2026,
author = {Yildiz, Ayla and Topuz, Hanim Seyma and Onal, Hasan},
title = {Metabolic and mitochondrial alterations in children with autism spectrum disorder: The role of FGF-21 and GDF-15},
journal = {Clinica Chimica Acta},
year = {2026},
doi = {10.1016/j.cca.2026.120979}
}
EUVIMED